The Billion Dollar Blind Spot: Why We Built the FemmeHealth Alliance
When ideas mature into infrastructure: reflections on the launch of the FemmeHealth Alliance and the next chapter of The Billion Dollar Blind Spot.
This newsletter is free. But it takes hours each week to research, write, and produce at this level. Here are 5 ways to support my work: 1. click “❤️” to amplify 2. subscribe 3. share this publication 4. buy me coffee 5. become a partner
Connect and collaborate with me here! Email | LinkedIn | Instagram
When the webinar ended, I didn’t close my laptop right away. The room was quiet except for the hum of the screen, still lit with the last slide: “Where capital, science, and policy align.”
For a moment, I just watched it. The cursor blinked like a heartbeat.
Something about that stillness felt different. For years, I’d been writing and speaking about the blind spot. The gap between what women need and where capital flows. But this week, that idea became something you could touch.
The FemmeHealth Alliance was born from a simple frustration: Europe has world-class science in women’s health, but no shared platform to turn that brilliance into funded, scalable solutions. Progress was happening but just in silos.
So we built a place to connect the dots.
The Alliance convenes investors, innovators, researchers, and policymakers around one shared table. We translate insights from labs and clinics into the language of capital. We surface data that helps policymakers understand where innovation is stuck and where it’s ready to move.
And we do it all with a single aim: to accelerate the path from discovery to deployment for women’s health solutions that can change lives. It sounds simple, but in practice, it’s radical because systems rarely talk to each other.
Research speaks science. Policy speaks risk. Capital speaks return.
FHA is where those languages meet.
New Here?
If you are an investor, operator, or women’s health advocate, start here.
→ Preorder the book: The Billion Dollar Blind Spot
→ Subscribe to the podcast: Blindspot Capital
→ Join the FemmeHealth Alliance Circle
Building the Bridge Between Capital, Science and Policy
In the days after the launch, I kept replaying one of the questions that came up in the chat: “What exactly will you do?” It’s a fair question and one that forces clarity. Because “bridging” can sound abstract until you see what it looks like in motion.
Here’s what it means.
It means a meeting that connects a researcher developing an early diagnostic for preeclampsia with an investor who understands how to navigate regulatory pathways so innovation doesn’t die in the lab.
It means convening European policymakers to align on funding gaps and help shape the next generation of women’s health investment frameworks.
It means creating data-driven insight reports that quantify market opportunity, helping private capital step in where public funding has retreated.
And it means hosting roundtables where scientists, founders, and investors look each other in the eye not as separate sectors, but as one ecosystem.
The Alliance exists to make collaboration routine instead of rare. To move from good intentions to measurable progress. To make “gender health equity” not just a goal, but an operating system.
And in that sense, the launch wasn’t just a milestone. It was proof that the idea is ready to stand on its own.
A Personal Thread
Behind this work sits a book I’ve been writing, The Billion Dollar Blind Spot, about how markets overlooked half the population, why the smartest money is finally moving, and what it means for anyone who wants to be part of the change.
This week’s launch felt like watching that thesis come alive.
For me, this project began long before there was a title, a website, or a logo. It began with a question, the kind that doesn’t let you go: Why do we still call it a “niche” when it affects half of humanity?
That question took me from investment boardrooms to hospital corridors, from macro strategy decks to late-night conversations with founders building what the market wouldn’t fund.
Each conversation made the same pattern visible: women’s health isn’t broken. It’s mispriced. And when something is mispriced, the market opportunity is bigger than anyone realises.
That’s what The Billion Dollar Blind Spot is about. But this week, it became more than a phrase.
It became a platform - a living, breathing infrastructure for change.
❤️ Enjoying this? If this post sparked something for you, click the ❤️ at the bottom. It helps more than you know and tells me you're reading.
From FemmeHealth Ventures to The Billion Dollar Blind Spot
Some of you have been reading this newsletter since its early days as FemmeHealth Ventures. What began as a space to share insights about investing in women’s health has evolved into something larger - a platform for systems thinking.
So, starting today, this newsletter continues under a new name: The Billion Dollar Blind Spot. It’s more than a rebrand. It’s a reflection of where the work has led and where it’s going next.
This is still the same Sunday space for stories, ideas, and context. But it’s also becoming the home for a broader conversation: about capital, gender, longevity, and the future of health innovation.
If FemmeHealth Ventures was about the “why,” The Billion Dollar Blind Spot is about the “what now.”
Timing & Momentum
There’s a rhythm to systemic change. A point when small signals start to synchronize. You can feel it across the market right now: new diagnostic startups, cross-disciplinary accelerators, the first generation of funds that treat women’s health as a growth sector, not a side note.
But momentum alone isn’t enough. Without coordination, innovation gets lost, brilliant founders burn out, research stalls, and capital stays cautious. That’s why the Alliance matters.
We’re not trying to reinvent the wheel. We’re trying to connect it. Each dialogue, each partner, each event is a small act of rewiring and aligning incentives so the system begins to function as a whole. This is how ideas mature into infrastructure. It’s how you move from awareness to architecture.
And it’s how we close the gap that’s cost women, families and the economy more than anyone can quantify.
An Invitation
If you’ve been reading these essays for a while, thank you. You are part of why this work exists and proof that curiosity and conviction can change how we see an entire sector.
Now, the next phase begins.
If you believe that women’s health innovation deserves the same capital coordination and policy attention as any other trillion-dollar industry, we’d love to have you with us.
👉 Join the FemmeHealth Alliance - a new platform bringing capital, science, and policy together across Europe.
Because the blind spot isn’t just a metaphor. It’s a market and a mission that’s finally coming into focus..
If this essay moved you, share or restack it.
This essay is part of my ongoing series on the billion-dollar blind spot in women’s health, wealth, and capital. You can subscribe to receive new essays every Sunday and join the conversation shaping the future of investing
To go deeper, pre-order my upcoming book The Billion Dollar Blind Spot to learn why women’s health is the future of healthcare investing.
Join Our Network
Are you building or backing credible, under-the-radar solutions in women’s health?
We want to hear from you. Reach out privately or reply to this post. FHV curates brands and breakthroughs that deserve broader attention in the women’s health ecosystem.
I write weekly at The Billion Dollar Blind Spot about capital, care, and the future of overlooked markets. If you are building, backing, or allocating in this space, I’d love to connect.
Disclaimer & Disclosure
This content is for informational and educational purposes only. It does not constitute financial, investment, legal, or medical advice, or an offer to buy or sell any securities. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making investment decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.